| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8651117 | American Heart Journal | 2017 | 12 Pages |
Abstract
Availability of DOACs increases the proportion of patients for whom oral anticoagulation therapy is recommended in a real-world cohort of AF patients and increased projected QALYs by more than 1,500 when all patients are receiving thromboprophylaxis as recommended by the AFDST compared with current treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mark H. MD, MS, Alexandru MD, Mehran MD, Jitender MD, Ruth E. MSN, MDes, Carol RN, Matthew L. MD, Pete BS, Robert Ireton, Brett M. MS-IS, Anthony C. PhD, Dylan MD, MS, Adam MD, John PhD,